STOCK TITAN

Perrigo Co Plc - PRGO STOCK NEWS

Welcome to our dedicated page for Perrigo Co Plc news (Ticker: PRGO), a resource for investors and traders seeking the latest updates and insights on Perrigo Co Plc stock.

Perrigo Company Plc (NYSE: PRGO) is a global provider of quality, affordable self-care products and over-the-counter health solutions. This dedicated news hub offers investors and industry professionals centralized access to official announcements, financial disclosures, and market developments.

Track Perrigo's strategic initiatives through verified press releases covering earnings results, product innovations, regulatory milestones, and partnership announcements. Our curated collection provides essential insights into the company's operations across key markets in North America, Europe, and global consumer health sectors.

Discover updates on Perrigo's store-brand leadership, branded OTC developments, and manufacturing advancements. The resource serves as a reliable reference for monitoring the company's progress in delivering accessible healthcare solutions through major retail partnerships and direct-to-consumer channels.

Bookmark this page for streamlined access to Perrigo's latest business updates, including analysis of market positioning in consumer self-care categories and operational efficiency programs. Stay informed about one of the OTC sector's most established innovators through verified, up-to-date information sources.

Rhea-AI Summary
Perrigo Company plc partners with WNBA to promote reproductive health through Opill®, the first daily birth control pill available without a prescription in the U.S., aiming to redefine contraception accessibility and empower women.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.48%
Tags
partnership
-
Rhea-AI Summary
Perrigo Company plc (PRGO) announces the availability of Opill®, the first daily birth control pill without a prescription in the U.S., for pre-order and in-store purchase at major retailers nationwide. Opill® is FDA-approved and priced at $19.99 for one-month and $49.99 for three-month packs. It aims to address barriers to contraceptive access and is 98% effective. Opill® is a significant advancement in reproductive health, offering a convenient and affordable option for preventing unintended pregnancies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.38%
Tags
none
-
Rhea-AI Summary
Perrigo Company plc (NYSE: PRGO) to present at UBS Global Consumer and Retail Conference. President and CEO, Patrick Lockwood-Taylor, and CFO, Eduardo Bezerra, to speak on March 13th. Webcast available on Perrigo's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.27%
Tags
conferences
Rhea-AI Summary
Perrigo Company plc (PRGO) achieved record net sales in the fourth quarter and fiscal year 2023, with improvements in gross profit, operating income, and EPS. The company launched 'Project Energize' to drive sustainable growth. Despite challenges in organic net sales, the company reported positive results and outlined future outlooks.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.14%
Tags
-
News
Rhea-AI Summary
Perrigo Company plc (NYSE: PRGO) increases its quarterly dividend by 1% to $0.276 per share, marking the 21st consecutive year of dividend growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.14%
Tags
dividends
-
Rhea-AI Summary
Perrigo Company plc (PRGO) is set to release its fourth quarter and fiscal year 2023 financial results on February 27th, 2024. The earnings conference call will be accessible via webcast or phone, with a replay available until March 5, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.98%
Tags
Rhea-AI Summary
Perrigo Company plc (NYSE: PRGO) announced the early tender results of its cash tender offer to purchase its 3.900% Senior Notes due 2024 in a principal amount of up to $300,000,000. The total principal amount of Notes validly tendered and not withdrawn as of the Early Tender Date is $385,548,000, representing 42.86% of the outstanding principal amount. The Tender Offer will expire on December 12, 2023, with settlement expected on December 15, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.39%
Tags
none
-
Rhea-AI Summary
Perrigo Company plc (NYSE: PRGO) Announces Commencement of Cash Tender Offer for Its 3.900% Senior Notes due 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.1%
Tags
none
-
Rhea-AI Summary
Perrigo Company plc (PRGO) reported a third-quarter net sales increase of 2.2% to $1.1 billion, with organic net sales decreasing 1.2%. The company achieved a gross margin of 36.6% and an adjusted gross margin of 39.5%. Reported EPS was $0.11, compared to a loss of $(0.39) in the prior year quarter. The company updates its fiscal 2023 organic net sales and total net sales growth outlook range to 1.0%-3.0% and 4.0%-6.0%, respectively.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.04%
Tags
News
Rhea-AI Summary
Perrigo Company plc (NYSE: PRGO) has declared a quarterly dividend of $0.273 per share. The dividend will be payable on December 19, 2023, to shareholders of record on December 1, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags
dividends
Perrigo Co Plc

NYSE:PRGO

PRGO Rankings

PRGO Stock Data

3.42B
135.92M
0.34%
101.68%
3.35%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2